HALEON US HOLDINGS LLC

General review and monitoring of U.S. diplomatic relations.

General review and monitoring of the National Defense Authorization Act (NDAA).

H R.5371 - Continuing Appropriations and Extensions Act, 2026, in particular provisions under Title V related to Over-the-Counter Monograph Drug User Fee Amendments.

General review and monitoring of legislative and administrative actions related to the design, development, and deployment of artificial intelligence platforms, especially as related to healthcare, over the counter settings, and protection of personally identifiable information.

General monitoring of issues and administrative action related to intellectual property protection.

General monitoring of legislative and administrative action related to health care policy; including the reauthorization of the OTC Monograph Drug User Fee Program (OMUFA); H R.5371 - Continuing Appropriations and Extensions Act, 2026, in particular provisions under Title V related to Over-the-Counter Monograph Drug User Fee Amendments. H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments; H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.2292 - Over-the-Counter Monograph Drug User Fee Amendments; S.2513 - OTC Monograph Drug User Fee Transparency Act; S.3122 - Better FDA Act of 2025 General monitoring of legislative and administrative action related to womens health issues; General monitoring of legislative and administrative action related to over-the-counter consumer healthcare products; General monitoring of legislative and administrative action related to dietary supplements, multivitamin, and hunger issues; General monitoring of legislative and administrative action related to FDA monograph reform and user fees; General monitoring of legislative and administrative action related to the switch of prescription medications to over-the-counter medications; Review of coverage for medically necessary services in Medicare and Medicare Advantage, Review of legislation impacting the Dietary Supplement Health and Education Act of 1994; General review of legislation and amendments focusing on non-addictive, non-opioid pain management medications, with a focus on over-the-counter (OTC) options; and General monitoring and review of Executive Order 14273, particularly section 9(b) as related to improvements to the process through which prescription drugs can be reclassified as over-the-counter medications, including recommendations to optimally identify prescription drugs that can be safely provided to patients over the counter. Monitoring and review of federal rulemaking processes on Increasing Access to Nonprescription Drugs.

General monitoring of legislative and administrative action related to Medicare and Medicaid policy, including changes in coverage/eligibility, including H.R. 1; General monitoring of Medicare/MA coverage of dental services; and General review of legislation and rulemaking impacting dual eligible enrollees.

General monitoring of Issues related to federal tax amortization of research and development expenses; General review and monitoring of legislation that includes over-the-counter dietary supplement products, specifically multivitamins, as qualified medical expenses; General review and monitoring of legislation and administrative action related to oral healthcare products, including specialty toothpastes and rinses, as qualified medical expenses under HSA/FSA; General review and monitoring of implementation of One Big Beautiful Bill Act (OBBBA)

Monitor and review of issues related to the Section 301 tariffs; Monitor and review of issues related to the Section 232 tariffs; Monitor and review of issues related to reciprocal tariffs under International Economic Emergency Powers Act; General monitoring and review of Executive Order 14257 and impacts on OTC products; General monitoring and review of legislative and executive actions on international trade policy related to tariffs, import/export concerns; General monitoring of legislative and administrative action related to review of the United States-Mexico-Canada Agreement (USMCA); and General review and monitoring of global supply chain concerns

General monitoring and review of issues and executive actions related to or impacting multivitamins and nutrition.

General review of legislative and administration action related to pediatric over-the-counter medication concerns.

General review and monitoring of processes impacting over-the-counter switches.

General review and monitoring on efforts aimed at preventing youth consumption of tobacco products; General review and monitoring of smoking cessation and over-the-counter alternatives for adult consumers.

General issues related to the manufacturing and supply chain resiliency of over-the-counter medications, specifically as it relates to additional domestic production of healthcare products; General monitor and review of legislative and administrative action related to domestic supply chain and manufacturing capabilities.

General monitoring of legislative and administrative action related to sustainability, particularly related to packaging and consumables. General monitoring and review of legislative and administration actions related to water consumption, particularly initiatives aimed at reducing water use or increasing savings.